4//SEC Filing
Londei Marco 4
Accession 0001209191-18-063384
CIK 0001370053other
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 9:48 PM ET
Size
20.4 KB
Accession
0001209191-18-063384
Insider Transaction Report
Form 4
ANAPTYSBIO INCANAB
Londei Marco
Chief Medical Officer
Transactions
- Sale
Common Stock
2018-12-17$65.36/sh−12,120$792,178→ 162,805 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2018-12-17−8,048→ 10,060 totalExercise: $0.70Exp: 2024-10-27→ Common Stock (8,048 underlying) - Exercise/Conversion
Common Stock
2018-12-17$0.70/sh+8,048$5,634→ 152,925 total - Sale
Common Stock
2018-12-17$67.57/sh−8,002$540,684→ 151,618 total - Sale
Common Stock
2018-12-17$68.47/sh−6,741$461,578→ 144,877 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2018-12-17−22,000→ 70,223 totalExercise: $6.93Exp: 2025-08-13→ Common Stock (22,000 underlying) - Exercise/Conversion
Common Stock
2018-12-17$6.93/sh+22,000$152,460→ 174,925 total - Sale
Common Stock
2018-12-17$66.38/sh−3,185$211,416→ 159,620 total
Footnotes (8)
- [F1]The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
- [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.00 to $65.99 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.00 to $66.92 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.02 to $68.01 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.05 to $68.73 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F6]The stock option vested and became exercisable as to 25% of the shares subject to the option on October 24, 2015, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.
- [F7]The stock option vested and became exercisable as to 25% of the shares subject to the option on August 13, 2016, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.
- [F8]In addition to the remaining options to purchase 80,283 shares of common stock as set forth in Table II, the Reporting Person also holds (i) 144,877 shares of common stock held directly; and (ii) additional options to purchase up to an aggregate of 138,000 shares of common stock, which options vest according to their terms.
Documents
Issuer
ANAPTYSBIO INC
CIK 0001370053
Entity typeother
Related Parties
1- filerCIK 0001654500
Filing Metadata
- Form type
- 4
- Filed
- Dec 17, 7:00 PM ET
- Accepted
- Dec 18, 9:48 PM ET
- Size
- 20.4 KB